November 5, 2019
Type 1 diabetes management and CGM integration are now on the table for WellDoc’s BlueStar, a management platform well known for being the first mobile health product to secure reimbursement as a diabetes therapy.
Thanks to a new FDA clearance, the company’s seventh, BlueStar will include integrated glucose level insights related to food, medication and activity that are based on the data from...
October 29, 2019
Life insurer John Hancock has unveiled a new wearable program dubbed Aspire aimed at helping its members with diabetes manage the condition. The program was born out of a partnership with Verily and digital diabetes care platform Onduo.
Users of the new platform can access diabetes coaching via Onduo’s virtual clinic. The program also has fiscal rewards. According to the company, members using...
September 30, 2019
Fitbit and Taiwan-based diabetes management app Health2Sync announced last week that Fitbit health, sleep and fitness data can now be integrated with the Health2Sync app to support Health2Sync’s 360,000 users in Taiwan and Japan to better manage their diabetes.
The voluntary integration of Fitbit data with the Health2Sync platform gives users who have a Fitbit account access to an in-app...
July 31, 2019
Hello Heart, maker of a digital chronic disease health program for employees, has raised $12 million in Series B funding. The round was led by Khosla Ventures, with additional support from previous backers BlueRun Ventures, Maven Ventures and Resolute Ventures.
WHAT THEY DO
Hello Heart’s bread and butter is its app-driven platform for hypertension, blood pressure and general cardiovascular health...
July 17, 2019
Following a major sales bump in the second quarter of 2019, Abbott Laboratories is planning to significantly ramp up manufacturing for its FreeStyle Libre continuous glucose monitoring system, the company shared during an investor’s call this morning.
Specifically, the company highlighted a 72.9% increase in organic sales growth during the three-month period, reaching a worldwide total sales...
July 15, 2019
Gone are the days of endless finger pricks to test blood glucose levels and complicated mental calculations to deduce carbohydrate ratios with insulin. The growth of people with diabetes by 314 million in the last 34 years has created an ever-expanding market in diabetes management products.
Consumers are now inundated with new technology streamlining lives with less needles and more real-time...
July 1, 2019
One Drop’s wireless blood glucose monitor is now being sold in certain US Apple Stores, according to a release from the company.
One Drop’s platform, which is integrated with Apple’s Health Records, allows iPhone users to more conveniently check their glucose levels and share that data, alongside the rest of their personal health record, with providers. Additionally, purchase of the system at an...
Screengrab of the Wellthy Therapeutics website.
June 12, 2019
At the 79th Annual Scientific Sessions of the American Diabetes Association in San Francisco, pharma giant Roche and India-based digital therapeutics company Wellthy Therapeutics presented real world data of improved diabetes care outcomes in a South Asian population when patients followed prescribed plan of medication and lifestyle modification in conjunction with a combination therapy of self-...
May 20, 2019
On Friday, the FDA issued a warning to patients and providers describing the dangers of diabetes management devices and software that haven’t been assessed by the agency. These include any unapproved or unauthorized continuous glucose monitors, insulin pumps and automated insulin dosing systems, whether used as a standalone device or integrated as part of a glucose management system.
March 20, 2019
Chronic disease management platform Hello Heart will now integrate with LifeScan OneTouch meters as part of its program for diabetes management.
The Redwood City, California-based company started out in hypertension, but has been expanding into diabetes for the past year. OneTouch meters, formerly owned by Johnson & Johnson, are the first of a handful of glucometer brands the company intends...